Apart from demonstrating the capacity of IL-1β to predict hyperfiltration in patients with severe obesity, their study had another valuable result – patients in whom GFR did not normalize after MBS also showed failure to normalize circulating IL-1β/Caspase-1 levels (53). The gene discussed is IL1B; the disease is obesity disorder.